Kaposi's disease in a patient on adalimumab for rheumatoid arthritis.
Bret
Johan
J
Hernandez
Julie
J
Aquilina
Christian
C
Zabraniecki
Laurent
L
Fournie
Bernard
B
D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006716:Homosexuality; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014983:Xeroderma Pigmentosum / Q000209:etiology* / Q000821:virology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab